INNOGI
LIVE

Serial Number

79411173

Owner

TIM Holding B.V.

Attorney

Brent E Routman

Filing Date

Aug 21, 2024

Add to watchlist:

No watchlists yet
View on USPTO

INNOGI Trademark

Serial Number: 79411173 • Registration: 8097783

INNOGI is a trademark filed by TIM Holding B.V. on August 21, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

TIM Holding B.V. (5 trademarks)

Thijsseweg 11

Entity Type: 78

Trademark Details

Filing Date

August 21, 2024

Registration Date

January 13, 2026

Published for Opposition

November 25, 2025

Goods & Services

Medical services; veterinary services; hygienic and beauty care services for human beings or animals; agriculture, horticulture and forestry services, namely, food nutrition consultation relating to crops and plant-based food agricultural advice; pharmaceutical services, namely, dispensing of pharmaceuticals; pharmaceutical advice; medical analysis services relating to the treatment of persons; medical consultancy; medical testing services; nutritional advisory services; provision of information relating to nutrition; medical counseling relating to disease risk, namely, risk assessment surveys with regard to health, nutrition and medicine; medical services relating to testing of medicine; rental and lease of apparatus for medical use.

Software, including software in the field of nutrition and pharmaceutical products, namely downloadable software for modeling, simulating and analyzing the digestion, absorption and bioavailability of orally administered pharmaceutical and food products, including prediction of blood plasma values; simulation and test equipment, namely, medical and veterinary training simulators in the nature of gastrointestinal models and laboratory testing apparatus for research laboratory use for assessing absorption, stability and bioavailability of food, pharmaceuticals, and dietary supplements

Scientific and technological services, namely, scientific research, analysis and testing in the field of gastrointestinal physiology, oral drug delivery, and nutrition sciences, and product research and design relating thereto; industrial analysis and research services in the field of biotechnology, pharmacology and food sciences; pharmaceutical research and analysis services in the nature of product evaluation; chemical research and analysis services; medical research; quality checking in the nature of product quality testing; testing of machinery and materials; laboratory testing services, namely, laboratory research in the field of oral drug delivery, gastrointestinal physiology, bacteriology, chemistry, toxicology, pharmaceuticals, and food sciences; rental and lease of computer software for scientific control, modelling, simulation and data analysis in the field of oral administration, drug delivery and nutrition sciences and apparatus for scientific and technological use, namely, rental of laboratory apparatus and instruments, rental of laboratory testing apparatus for pharmaceuticals and food products; toxicology research services, namely, evaluating and assessing toxicological information in relation to risks; scientific research consultancy in the field of toxicology; testing of foodstuffs; platform as a service (PAAS) featuring software platforms for transmission of images, audio-visual content, video content, data and messages

Medical apparatus and instruments including medical testing apparatus, namely, medical apparatus for testing in the nature of in-vitro gastrointestinal model apparatus for testing digestion, absorption and bioavailability of orally administered food and pharmaceutical products, medical diagnostic apparatus for testing gastrointestinal function, and apparatus for medical purposes used in medical laboratories for testing gastrointestinal motility, microbiome activity, and fluid dynamics

Pharmaceuticals, medical and veterinary preparations, namely, pharmaceutical and medical preparations for the development, testing and evaluation of orally administered pharmaceutical products and veterinary preparations for the development, testing and evaluation of orally administered veterinary products in the nature of reagents for medical use, reagents for veterinary purposes and cell culture media for medical or veterinary purposes, namely for testing pharmaceutical, medical or veterinary products, other than for research and scientific purposes; dietetic food and substances adapted for medical or veterinary use, namely, dietetic preparations adapted for medical purposes, dietetic foods adapted for medical use, dietetic sugar substitutes for medical use, and nutritionally fortified beverages for medical use; food for babies; dietary supplements for human beings and animals; preparations for destroying vermin; fungicides, herbicides

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 21, 2026 OPNX
LIMITATION OF GOODS RECEIVED FROM IB
May 14, 2026 LIMG
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 4, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 4, 2026 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 13, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 13, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 13, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 25, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 25, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 19, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 29, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 28, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 28, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 28, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 28, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 28, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 28, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 28, 2025 TROA
REFUSAL PROCESSED BY IB
Apr 19, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 31, 2025 RFCS
REFUSAL PROCESSED BY MPU
Mar 31, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 25, 2025 RFCR
NON-FINAL ACTION WRITTEN
Feb 24, 2025 CNRT
ASSIGNED TO EXAMINER
Feb 19, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 5, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 5, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 5, 2024 REPR